Clinical Trial Update: Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-up trial of low-dose tamoxifen in women with breast intraductal carcinoma (DCIS) to assess continued efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hyperplasia
• Breast Neoplasms
• Carcinoma Intraductal Noninfiltrating
• Recurrence Local Neoplasm

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Andrea DeCensi | Conditions: Carcinoma, Intraductal, Noninfiltrating, Recurrence, Local Neoplasm | Phase 3 | Status: ACTIVE_NOT_RECRUITING